(Topical) Quercetin might be a good add on to the hair loss stack
    7/25/2023

    New to Quercetin? There is a guide in the encyclopedia. Read the guide →
    At a glance
    In this hair loss treatment regimen post, the primary subjects mentioned are
    💧 Quercetin (topical)
    the tone is 😐 neutral.

    Other terms

    Quercetin might help with hair loss by inhibiting HSP-70, which increases androgen receptors. Concerns include its staining properties and unclear topical absorption.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Effects of Flavonoid Derivatives on Human Microvascular Endothelial Cells

      research Effects of flavonoid derivatives on human microvascular endothelial cells

      9 citations , March 2016 in “Natural Product Research”
      This study found that baicalin promotes human microvascular endothelial cell proliferation, while visnadin and minoxidil enhance tubulogenesis, with hesperidin uniquely increasing VEGFR-2 phosphorylation compared to other compounds tested.
      Effect of Estrogens on Skin Aging and the Potential Role of SERMs

      research Effect of estrogens on skin aging and the potential role of SERMs

      120 citations , October 2007 in “Clinical Interventions in Aging”
      This review discusses the effects of estrogens on skin aging and highlights the potential benefits of estrogen replacement therapy and selective estrogen receptor modulators for improving skin health in postmenopausal women, but reports no new clinical findings.
      New Therapeutics in the Management of Androgenetic Alopecia

      research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique

      March 2025 in “HAL (Le Centre pour la Communication Scientifique Directe)”
      This thesis investigates the underlying mechanisms and treatment options for androgenetic alopecia, highlighting the molecular roles of androgens and genetic predispositions, and evaluates current and emerging therapies, such as PROTACs and Janus Kinase inhibitors, to enhance patient management.